Nebivolol: The Role of Nitric Oxide in HypertensionZANCHETTI, Alberto; REID, John L.Journal of cardiovascular pharmacology. Supplement. 2001, Vol 38, Num 3, 41 p.Serial Issue

Endothelial dysfunction in hypertensionTADDEI, Stefano; VIRDIS, Agostino; GHIADONI, Lorenzo et al.Journal of cardiovascular pharmacology. Supplement. 2001, Vol 38, Num 2, pp S11-S14Conference Paper

Vascular effects of newer cardiovascular drugs: Focus on nebivolol and ACE-inhibitorsLÜSCHER, Thomas F; SPIEKER, Lukas E; NOLL, Georg et al.Journal of cardiovascular pharmacology. Supplement. 2001, Vol 38, Num 3, pp S3-S11Article

Metabolic effects and safety profile of nebivololPESSINA, Achille C.Journal of cardiovascular pharmacology. Supplement. 2001, Vol 38, Num 3, pp S33-S35Article

Comparison of neurohumoral effects of short-acting and long-acting loop diuretics in patients with chronic congestive heart failureTSUTSUI, Takashi; TSUTAMOTO, Takayoshi; MAEDA, Keiko et al.Journal of cardiovascular pharmacology. Supplement. 2001, Vol 38, Num 1, pp S81-S85Conference Paper

Endothelin antagonism does not affect adrenal catecholamine secretion and system haemodynamics during acute stress in Wistar ratsZARETSKY, Dmitry V; ZARETSKAIA, Maria V; KALENIKOVA, Elena I et al.Journal of cardiovascular pharmacology. Supplement. 2000, Vol 36, Num 1, pp S374-S376Conference Paper

Plasma endothelin levels are unaltered by thyroid hormone status in humansLAM, Hing-Chung; LEE, Jenn-Kuen; LAI, Kwok-Hung et al.Journal of cardiovascular pharmacology. Supplement. 2000, Vol 36, Num 1, pp S382-S385Conference Paper

Endothelins are angiogenicBEK, Eugene L; MCMILLEN, Marvin A.Journal of cardiovascular pharmacology. Supplement. 2000, Vol 36, Num 1, pp S135-S139Conference Paper

Endothelin stimulates glucose uptake via activation of endothelin-A receptor in neonatal rat cardiomyocytesWU-WONG, Jinshyun R; BERG, Cathleen E; KRAMER, Debra et al.Journal of cardiovascular pharmacology. Supplement. 2000, Vol 36, Num 1, pp S179-S183Conference Paper

Mitochondrial dysfunction increases expression of endothelin-1 and induces apoptosis through caspase-3 activation in rat cardiomyocytes in vitroYUKI, Koichi; MIYAUCHI, Takashi; KAKINUMA, Yoshihiko et al.Journal of cardiovascular pharmacology. Supplement. 2000, Vol 36, Num 1, pp S205-S208Conference Paper

Increased susceptibility to deoxycorticosterone acetate-salt-induced hypertension in endothelin-B-receptor-deficient ratsMATSUMURA, Yasuo; KURO, Toshihiko; KOBAYASHI, Yutaka et al.Journal of cardiovascular pharmacology. Supplement. 2000, Vol 36, Num 1, pp S86-S89Conference Paper

Endothelin-1-induced contraction of rat thoracic aorta depends on calcium entry through three types of calcium channelZHANG, Xiao-Feng; IWAMURO, Yasushi; OKAMOTO, Yasuo et al.Journal of cardiovascular pharmacology. Supplement. 2000, Vol 36, Num 1, pp S105-S106Conference Paper

Endothelin regulates angiotensin-converting enzyme in the mouse kidneyBARTON, Matthias; CARMONA, Renata; KRIEGER, José E et al.Journal of cardiovascular pharmacology. Supplement. 2000, Vol 36, Num 1, pp S244-S247Conference Paper

Effects of Endothelin receptor antagonists on the plasma immunoreactive endothelin-1 levelOPGENORTH, Terry J; WESSALE, Jerry L; DIXON, Douglas B et al.Journal of cardiovascular pharmacology. Supplement. 2000, Vol 36, Num 1, pp S292-S296Conference Paper

Glucocorticoids decrease endothelin-A- and -B-receptor expression in the kidneyVILLENEUVE, Annie; GIGNAC, Sonia; PROVENCHER, Patricia H et al.Journal of cardiovascular pharmacology. Supplement. 2000, Vol 36, Num 1, pp S238-S240Conference Paper

Inhibitor potencies and substrate preference for endothelin-converting enzyme-1 are dramatically affected by pHFAHNOE, Douglass C; KNAPP, Jill; JOHNSON, Gary D et al.Journal of cardiovascular pharmacology. Supplement. 2000, Vol 36, Num 1, pp S22-S25Conference Paper

Cellular expression of isoforms of endothelin-converting enzyme-1 (ECE-1c, ECE-1b and ECE-1a) and endothelin-converting enzyme-2DAVENPORT, Anthony P; KUC, Rhoda E.Journal of cardiovascular pharmacology. Supplement. 2000, Vol 36, Num 1, pp S12-S14Conference Paper

Endothelin antagonists and renal protectionBENIGNI, Ariela; PERICO, Norberto; REMUZZI, Giuseppe et al.Journal of cardiovascular pharmacology. Supplement. 2000, Vol 35, Num 2, pp S75-S78Conference Paper

New insights into the therapeutic mechanism of action of calcium channel blockers in salt-dependent hypertension : Their interaction with endothelin gene expressionGODFRAIND, Théophile.Journal of cardiovascular pharmacology. Supplement. 2000, Vol 35, Num 1, pp S31-S40Conference Paper

Mechanisms and clinical implications of blood pressure variabilityMANCIA, Giuseppe; GRASSI, Guido.Journal of cardiovascular pharmacology. Supplement. 2000, Vol 35, Num 4, pp S15-S19Conference Paper

Long-term regulation of catecholamine formation by ouabain in cultured bovine adrenal chromaffin cellsOZAWA, Yuichi; HOUCHI, Hitoshi; TERAOKA, Kazuhiko et al.Journal of cardiovascular pharmacology. Supplement. 2000, Vol 36, Num 2, pp S15-S18Conference Paper

How can hypertensive patients be better treated? The contribution of combination therapyBENETOS, A; GUIZE, L; RUDNICHI, A et al.Journal of cardiovascular pharmacology. Supplement. 2000, Vol 35, Num 3, pp S13-S16Conference Paper

Regulation of the myocardial endothelin system by angiotensin-II and losartanMCEWAN, Pauline E; SHERRY, Lorcan; KENYON, Christopher J et al.Journal of cardiovascular pharmacology. Supplement. 2000, Vol 36, Num 1, pp S144-S147Conference Paper

Relationship between soluble intracellular endothelin-converting enzyme and endothelin-1 synthesis: Effect of inhibitors of the secretory pathwayCORDER, Roger; KHAN, Noorafza Q; HARRISON, Vanessa J et al.Journal of cardiovascular pharmacology. Supplement. 2000, Vol 36, Num 1, pp S19-S21Conference Paper

Selective antagonism of endothelin-A-receptors improves outcome in both head trauma and focal stroke in ratBARONE, Frank C; OHLSTEIN, Eliot H; HUNTER, A. Jackie et al.Journal of cardiovascular pharmacology. Supplement. 2000, Vol 36, Num 1, pp S357-S361Conference Paper